Dr Pat Carragher has been named as a winner in the prestigious national 2022 WellChild Awards, in association with GSK, having been nominated by his colleague Emma Craig.
Pat will be off to collect his award in London on September 8th.
The Awards are run by WellChild, the national charity for seriously ill children, and will be attended by the charity’s Patron, Prince Harry, The Duke of Sussex and his wife Meghan, The Duchess of Sussex. The Duke will deliver remarks.
Dr Carragher, who is Medical Director at Children’s Hospices Across Scotland, was picked from hundreds of nominations from across the UK to win the Legacy category in these Awards which celebrate the resilience of children living with serious illnesses or complex conditions and honour the dedication of those individuals who go the extra mile to help these children and their families.
In summer of 2022, Dr Pat Carragher will be retiring as Medical Director at CHAS after nearly 39 years of working as a doctor. He has encountered periods of great change in his years as a medic including in Primary Care when he was a GP in Kinross before becoming Rachel House’s first hospice doctor and formally beginning work in Children’s Palliative Care in March 1996.
Dr Carragher has led the changes to CHAS’s medical service provisions through the Covid-19 pandemic. Despite the challenges the pandemic brought, alongside the team, he was determined to find ways to continue to reach the thousands of children with life-shortening conditions that rely on CHAS.
He helped establish new and innovative ways of working using technology to provide help to families across Scotland and proved himself to be a strong and resilient leader through immense change. He has reshaped CHAS’s medical services, helping families during what continues to be an isolating and unpredictable time.
Within three to four weeks from the start of the Coid-19 Pandemic, CHAS completely adapted its service offering to survive and to maintain the very best standards of care for children with palliative care needs, and to support their families.
Dr Carragher also led on virtual work through the “Near me” consultations via the NHS and by the use of Microsoft Teams, to interact with and assess children at home, and to work with their parents.
CHAS’s pioneering virtual children’s hospice was also launched at the beginning of the pandemic and has rapidly developed since proving to be extremely successful.
Dr Carragher has also helped lead the CHAS hospital teams in Glasgow, Aberdeen and Edinburgh through this period of transformation, providing clinical leadership and support in the planning and delivery of palliative care whilst working closely with the NHS and local authorities.
He was key in launching the first hospital-based Supportive and Palliative Care team in Scotland at the Royal Hospital for Children in Glasgow and has continued to provide specialist advice through the pandemic.
Rami Okasha, the Chief Executive Officer of Children’s Hospices Across Scotland, who nominated Dr Carragher for the WellChild Award, said: “Dr Pat’s leadership and strength of character has enabled the team to adapt in ways which they never imagined. He’s shown resilience and an unwavering drive for reaching all of those who require CHAS’s help, and he’s inspired not only the medical team but all teams.”
“Dr Pat was continuously able to inspire and encourage teams to ‘keep going’ during the pandemic and to embrace the new and innovate ways to deliver care. He has provided solid leadership throughout this period of immense change.
“Dr Carragher ends many presentations with the following which he feels is vital for us all to understand: ‘The death of a child has serious and lasting effects on parents and other family members, effectively for the rest of their lives. Any attempt to reduce symptoms and improve quality of life in the final days or weeks, must not only be good for a child but, in the fullness of time, be helpful to those left behind‘.”
WellChild Chief Executive, Matt James said: “There are more children and young people than ever before in the UK living with long-term, serious health needs.
“The WellChild Awards 2022, in association with GSK, will be a unique opportunity to recognise and highlight the immense challenges they have faced and to celebrate the remarkable positivity, resilience and spirit they have demonstrated.
“It will also help us to shine a light on the dedication of those around them, from siblings, professionals and volunteers who have gone above and beyond to help them through such challenging times.”
24
0
20
